Coloplast A/S (CLPBY)
7.64
+0.11
(+1.46%)
USD |
OTCM |
Feb 20, 16:00
Coloplast Shareholders Equity (Quarterly) : 2.171B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Genmab A/S | 5.847B |
| Ascendis Pharma A/S | -191.23M |
| Zealand Pharma A/S | 2.332B |
| Bavarian Nordic A/S | 2.071B |
| ALK-Abello A/S | 971.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.673B |
| Total Liabilities (Quarterly) | 5.502B |
| Debt to Equity Ratio | 1.818 |
| Current Ratio | 1.299 |
| Net Debt Paydown Yield | -0.58% |